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The crystal structure of human S-adenosylmethionine
decarboxylase at 2.25 Å resolution reveals a novel fold
Jennifer L Ekstrom1, Irimpan I Mathews1, Bruce A Stanley2, Anthony E Pegg3
and Steven E Ealick1*
Background: S-Adenosylmethionine decarboxylase (AdoMetDC) is a critical
regulatory enzyme of the polyamine synthetic pathway, and a well-studied drug
target. The AdoMetDC decarboxylation reaction depends upon a pyruvoyl
cofactor generated via an intramolecular proenzyme self-cleavage reaction.
Both the proenzyme-processing and substrate-decarboxylation reactions are
allosterically enhanced by putrescine. Structural elucidation of this enzyme is
necessary to fully interpret the existing mutational and inhibitor-binding data,
and to suggest further experimental studies.
Results: The structure of human AdoMetDC has been determined to 2.25 Å
resolution using multiwavelength anomalous diffraction (MAD) phasing methods
based on 22 selenium-atom positions. The quaternary structure of the mature
AdoMetDC is an (αβ)2 dimer, where α and β represent the products of the
proenzyme self-cleavage reaction. The architecture of each (αβ) monomer is a
novel four-layer α/β-sandwich fold, comprised of two antiparallel eight-stranded
β sheets flanked by several α and 310 helices.
Conclusions: The structure and topology of AdoMetDC display internal
symmetry, suggesting that this protein may be the product of an ancient gene
duplication. The positions of conserved, functionally important residues suggest
the location of the active site and a possible binding site for the effector
molecule putrescine.
Introduction
S-Adenosylmethionine decarboxylase (AdoMetDC) is a
critical regulatory enzyme in the polyamine synthetic
pathway, and has been the subject of biochemical studies
spanning several decades [1]. AdoMetDC is a target for
drug design against cancer, parasitic infection, and a variety
of hyperproliferative disorders and has several intriguing
biochemical features such as an unusual self-cleavage reac-
tion, a covalently bound reactive pyruvoyl group, allosteric
activation, and high in vivo degradation rates. 
AdoMetDC catalyzes the removal of the carboxylate group
from S-adenosylmethionine (AdoMet) to form S-adenosyl-
5′-3-methylthiopropylamine (dcAdoMet) (Figure 1), which
is committed to act as the n-propylamine group donor for
the synthesis of the polyamines spermidine and spermine
from the diamine putrescine. These polyamines have
been shown to be involved in the initiation and mainte-
nance of proliferative states, and are crucial for cell growth
and differentiation [2]. AdoMetDC is a control point
within the polyamine pathway, and its activity is highly
regulated during the cell cycle via multiple mechanisms
[3]. Deregulation of this pathway has been associated with
several types of cancers [4].
The unusual catalytic mechanism of AdoMetDC involves
a covalently bound pyruvoyl group instead of the cofactor
pyridoxal-5′-phosphate (PLP) typically employed in
amino acid decarboxylation reactions. AdoMetDC
belongs to a small group of pyruvoyl-dependent enzymes
(reviewed in [5,6]), which includes aspartate decarboxy-
lase (AspDC), phosphatidylserine decarboxylase, and the
prokaryotic histidine decarboxylase (HisDC). Similar to
these other amino acid decarboxylases, AdoMetDC gen-
erates the necessary active-site pyruvoyl residue via an
autocatalytic post-translational modification. AdoMetDC
is synthesized as a 38.3 kDa proenzyme (pi chain) that
undergoes a self-catalyzed intramolecular proteolytic
cleavage reaction at the Glu67–Ser68 peptide bond to
generate two chains, β and α, of molecular weight
7.7 kDa and 30.6 kDa, respectively. The convention in
the literature is to denote the smaller N-terminal chain,
which was overlooked in the original characterization of
the enzyme, as the β subunit. The post-translational
cleavage follows an unusual pathway, termed nonhydro-
lytic serinolysis, in which the sidechain OH group of
Ser68 supplies its oxygen atom to form the C terminus of
the β chain, while the remainder of the serine residue is
converted to ammonia and the pyruvoyl group blocking
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the N terminus of the α chain. The active AdoMetDC is
isolated as a 76.6 kDa (αβ)2 dimer, where α and β repre-
sent the two polypeptide chains created by the processing
reaction [6].
The AdoMetDC enzyme product, dcAdoMet, partici-
pates in two reactions, one with putrescine to form sper-
midine and another with spermidine to form spermine.
Interestingly, putrescine is an allosteric activator of
mammalian AdoMetDC, accelerating both the self-cleav-
age and the enzymatic-decarboxylation reactions. The
t1/2 of the processing reaction for human AdoMetDC
shortens from 2 hours to 15 minutes upon the addition of
millimolar putrescine [7], and the addition of submilli-
molar putrescine lowers the Km for the substrate fourfold
at pH 6.8 [8]. Thus, both the proportion of processed
AdoMetDC and its level of enzymatic activity are
enhanced by the availability of putrescine for the down-
stream reactions.
AdoMetDC also exhibits unusually high molecular degra-
dation/turnover rates, with an in vivo half-life of 1–2 hours
[2]. The short half-life of AdoMetDC is thought to be
related to the propensity for substrate-mediated transami-
nation of the enzyme [9–11]. These molecular-degrada-
tion rates are decreased significantly in the presence of
most inhibitors of catalytic activity [12,13].
The AdoMetDC amino acid sequence [14] is highly con-
served among mammals, but bears little similarity to that
of any other protein currently in the protein or nucleic
acid databases, including those of the other known pyru-
voyl-dependent amino acid decarboxylases. We report
the crystal structure of human AdoMetDC determined
to 2.25 Å resolution using selenomethionine multiwave-
length anomalous diffraction (MAD) phasing methods.
This structure presents a novel four-layer α/β-sandwich
fold. Extensive biochemical and mutational data allow us
to propose locations for the binding of both substrate
and effector. The lack of similarity between the three
currently known pyruvoyl-dependent amino acid decar-
boxylase structures indicates that the unusual mecha-
nism shared by these enzymes has arisen through
convergent evolution. An internal structural repeat
observed in the structure suggests that the AdoMetDC
enzyme is the product of an ancient gene duplication.
Results and discussion
MAD structure determination
MAD phasing has become a popular technique in the 
X-ray crystallographic determination of protein structures
and is being successfully applied to increasingly larger
systems. However, selenium-based MAD phasing
methods require the ability to locate large numbers of
anomalous scatterers. With 22 ordered selenium atoms
present in the asymmetric unit, AdoMetDC has one of the
largest anomalous scattering substructures solved to date.
The structure of S-adenosylhomocysteine hydrolase [15]
has been determined using 30 selenium atoms, and the
purine operon repressor from Bacillus subtilis [16] has been
determined using 36 selenium atoms.
Several existing programs have been used in locating
anomalous scattering substructures for MAD phasing. In
this study, the direct methods programs SnB [17,18] and
the automated Patterson search program SOLVE
(http://www.solve.lanl.gov) [19] were both used success-
fully to determine the selenium substructure. In the case
of SnB, both normalized structure factors (calculated from
Fa values) and diffE values (derived from the anomalous
differences for a single wavelength) were used in separate
runs. Only when single-wavelength diffE values were
used in SnB were all 22 selenium peaks identified for
AdoMetDC. Use of the peak wavelength data with careful
optimization of input parameters yielded the greatest
success rate, whereas use of Fa values obtained from the
MADSYS [20,21] package in SnB failed to produce the
bimodal distribution of Rmin values characteristic of a 
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Figure 1
AdoMetDC catalyzes the removal of the
carboxylate group of AdoMet to form
dcAdoMet. N
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successful SnB run. Twenty selenium peaks were identi-
fied using the program SOLVE. 
Refinement of the 22 selenium positions was performed
with two programs, MADSYS [20,21] and MLPHARE
[22]. Although each yielded maps that remained uninter-
pretable in the early stages of the refinement, many itera-
tions of MLPHARE coupled with adjustment of the error
estimates yielded a set of phases that improved signifi-
cantly after solvent flattening. A section of electron
density calculated from the solvent-flattened MAD phases
is shown in Figure 2.
AdoMetDC architecture and topology
AdoMetDC crystallizes in the monoclinic space group P21
with unit-cell dimensions of a = 74.6 Å, b = 55.8 Å,
c = 90.1 Å, and β = 109.6°. One functional (αβ)2 dimer,
with overall dimensions of 78 Å × 46 Å × 37 Å, is contained
in the asymmetric unit. A Cα trace and ribbon diagram of
the monomer are depicted in Figures 3a and b, and crystal
and refinement statistics may be found in Tables 1 and 2.
The architecture of each (αβ) monomer is a four-layer
α/β-sandwich fold, in which two central eight-stranded
antiparallel β sheets are flanked by several α and 310
helices on each outer side. The six α helices observed in
the monomer are all amphipathic, packing tightly against
the outer faces of the β sandwich. The region between the
α helices and the β sheets is very hydrophobic, with no
bound water observed. In each (αβ) monomer, the N-ter-
minal β subunit contributes three β strands, one α helix,
and one short 310 helix, and the C-terminal α subunit con-
tributes 13 strands, five α helices and three short 310
helices. Two proline residues, Pro126 and the conserved
Pro225, adopt a cis conformation in each monomer; no
disulfide bonds are observed. The α and β chains are
interlaced and do not form separate domains.
Several short segments of the protein are disordered. In
both monomers N-terminal and C-terminal residues are
invisible in the electron density, as well as three internal
loop regions of six to eight amino acids each. The
missing residues in monomer I are 1–3, 21–28, 165–171,
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Figure 2
A representative section of electron density
calculated at 2.25 Å resolution from the MAD
phases after solvent flattening with the
program DM. The electron density was
generated using the program Chain [47].
Table 1 
Crystallographic data*.
Data set f′ f′′ Resolution Measurements Unique Completeness (%) I/σI (%) Rsym (%)†
limit (Å) reflections
λ1 0.9791 Å –7.560 3.841 2.25 169,725 33,426 98.9 23.71 5.0
(98.1) (15.0) (9.4)
λ2 0.9788 Å –6.892 3.839 2.25 168,982 33,555 98.8 18.92 6.1
(96.9) (11.7) (11.1)
λ3 0.954 Å –2.818 3.636 2.25 169,222 33,342 98.9 23.43 5.0
(99.3) (13.9) (10.4)
*Values in parentheses are for the high-resolution shell (2.33–2.25 Å). Space group: P21; cell dimensions: a = 74.6 Å, b = 55.8 Å, c = 90.1 Å,
α = γ = 90°, β = 109.6°. †Rsym = ΣhklΣi|Iihkl–<Ihkl>|/Σhkl<Ihkl>, where Iihkl is the ith measurement and <Ihkl> is the weighted mean of all
measurements of Ihkl.
293–298 and 330–334, whereas those of monomer II are
1–4, 20–27, 67, 165–171, 293–298 and 329–334.
A topology diagram of the (αβ) monomer is shown in
Figure 3c. The N-terminal and C-terminal halves of each
(αβ) monomer exhibit a clear topological similarity. The
N-terminal β sheet (sheet I) and the C-terminal sheet
(sheet II) each consist of eight strands, both with a sheet
topology of β2-β3-β4-β5-β1-β6-β8-β7. Three α helices
(H2, H4, H6) and three short stretches of 310 helix (H1,
H3, H5) are arranged flanking sheet I on the outer side of
the β sandwich, whereas three α helices (H7, H8, H10)
and a single 310 helix (H9) flank sheet II.
Comparison with other protein structures
The topology of the four-layer α/β sandwich is different
from that of any currently known protein structure, reveal-
ing a new class of fold. The AdoMetDC monomer and
fragments thereof were submitted to the DALI server [23]
to identify other proteins of similar structure. No signifi-
cant similarities were uncovered between AdoMetDC and
other proteins currently in the Protein Data Bank (PDB).
In addition, the AdoMetDC structure was compared to
the two published pyruvoyl-dependent amino acid decar-
boxylase structures, those of Lactobacillus 30a histidine
decarboxylase (HisDC) [24–26] and Escherichia coli aspar-
tate decarboxylase (AspDC) [27]. Neither of these pro-
teins show similarity in sequence or overall structure to
AdoMetDC. This lack of homology is striking, as all three
of these enzymes undergo an autocatalytic, intramolecular
self-cleavage reaction, contain a pyruvoyl cofactor, and
catalyze analogous reactions. Although AdoMetDC,
AspDC, and HisDC are all α/β proteins with antiparallel
β sheets, their topologies and detailed tertiary and quater-
nary structures are distinct. AdoMetDC and HisDC both
have a four-layer α/β-sandwich architecture, whereas
AspDC has a six-stranded β-barrel structure. AdoMetDC
forms a dimer, HisDC forms a hexamer, and AspDC a
tetramer. AdoMetDC also differs from HisDC and
AspDC in the relative topological and structural position
of its active-site region. The pyruvoyl group of
AdoMetDC is far removed from the dimer interface,
located within a loop connecting two adjacent strands
within the first β sheet (Figures 3b and c). In contrast,
both HisDC and AspDC have active sites involving
residues of two adjacent subunits. The pyruvoyl group of
HisDC is located in a loop connecting two separate
β sheets, and the pyruvoyl group of AspDC is located in a
loop connecting two nonadjacent strands within the same
β sheet. The absence of any clear structural similarity
between AdoMetDC, HisDC and AspDC supports the
hypothesis of convergent evolution in the creation of their
similar catalytic functions.
Additionally, comparison of the topology of AdoMetDC
and other proteins containing large β sandwiches, for
example pea lectin [28], shows that AdoMetDC is unique
in that all eight strands making up each of the two
β sheets come from the same part (N-terminal or C-termi-
nal) of the primary sequence. Consequently, there is only
one covalent link between the two sheets (Figure 3c).
The absence of multiple crossovers between the sheets
may allow for flexibility in their association.
The dimer interface of AdoMetDC
The dimer interface of AdoMetDC buries approximately
1000 Å2 of molecular surface area per monomer and
shows an interesting mode of association. Pairs of (αβ)
monomers related by the noncrystallographic twofold
axis are joined by an edge-on association of β sheets to
form the (αβ)2 dimer (Figure 4). The β15 strand of each
monomer is joined to its counterpart through four main-
chain–mainchain hydrogen bonds, connecting sheet II of
each monomer so as to form a 16-stranded β sheet with
good geometry. Near the ends of strand β15, four addi-
tional mainchain–mainchain interactions are mediated
via the hydrogen bonding of crystallographically
observed water molecules. In contrast, the interaction
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Table 2
Phasing and refinement statistics.
MAD phasing statistics (25.0–2.25 Å resolution)
λ1 to λ3
Rcullis (acentric/centric)* 0.72/0.74
Rcullis–anomalous* 0.62
Phasing power (acentric/centric)* 1.55/1.02
FOM† 0.658
λ2 to λ3
Rcullis (acentric/centric)* 0.70/0.72
Rcullis–anomalous* 0.59
Phasing power (acentric/centric)* 1.62/1.07
Refinement statistics (20.0–2.25 Å resolution)
Number of reflections 31,619
Resolution 20–2.25 Å
Rcryst‡ 0.177
Rfree§ 0. 229
Rmsd bonds (Å) 0.009
Rmsd angles (°) 1.443
Rmsd NCS (Å) (number of atoms) 0.0316
Number of atoms
protein monomer A 2481
protein monomer B 2447
water 414
Mean B value (Å2)
protein monomer A 20.214
protein monomer B 19.807
water 25.979
Ramachandran plot
residues in most favored regions (%) 89.6
residues in additional allowed regions (%) 9.7
residues in generously allowed regions (%) 0.4
residues in disallowed regions (%) 0.2
*Rcullis, Rcullis–anomalous, and phasing power are defined in MLPHARE
[22]. †Figure of merit. ‡Rcryst = Σ(|Fobs|–|Fcalc|) / Σ|Fcalc|. §Rfree is a cross-
validation residual calculated using 5% of the data, which were
randomly chosen and excluded from the refinement [44].
between the remaining pair of twofold-related sheets
(sheet I/sheet I) is distorted and involves several
hydrophilic sidechain residues. The participating
strands, β7 of each monomer, are distorted as a result of a
β bulge in the vicinity of residues 148–150, and form
only two direct mainchain–mainchain hydrogen bonds.
However, six sidechain–sidechain hydrogen bonds are
observed between the β7 strands, and additional hydro-
gen-bonding interactions occur through four water mol-
ecules buried within the interface.
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Figure 3
Structure and topology of the AdoMetDC
monomer. (a) Stereo Cα trace of the
AdoMetDC monomer. Every tenth Cα atom is
labeled. (Figures 3a and b were generated
using MOLSCRIPT [48]). (b) Stereo ribbon
diagram of the AdoMetDC monomer.
Secondary structural elements are labeled,
and the position of the pyruvoyl cofactor is
indicated by the gold asterisk. (c) Topology
diagram of AdoMetDC. Helices are
represented by circles, α helices are colored
blue and 310 helices are colored purple;β strands are represented by red triangles.
The break between the α and β chains is
indicated by the gold star. The N–C direction
of the secondary structural elements (into or
out of the page) can be deduced from the
connecting lines. If the N-terminal connection
is drawn to the edge of the symbol and the
C-terminal one to the center of the symbol,
then the direction is up; otherwise, the
N-terminal connection is drawn to the center
and the C-terminal one to the edge and the
direction is down. 
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Evidence of an internal gene duplication
The DALI package [23] was used to superimpose the topo-
logically similar secondary structural elements observed in
the N-terminal and C-terminal halves of the monomer
(Figure 5), yielding a root mean square (rms) difference of
1.8 Å between the 55 pairs of aligned Cα atoms. The
observed structural similarity suggests that AdoMetDC
might be the product of an ancient gene-duplication event
and that the N-terminal and C-terminal regions are proba-
bly independent folding units. Internal gene duplications
have been observed in several protein structures, including
rhodanese, cytochrome b5, glutathione reductase, rubre-
doxin and hexokinase, among others [29].
This internal homology is not detectable from the
sequence; the identity between the aligned residues is
only 11%. Homology between the complete sequences of
the N-terminal and C-terminal halves is also not
detectable in the AdoMetDCs of other species. The gene-
duplication hypothesis is consistent with the observation
that the two halves are related by an approximate twofold
symmetry axis, the absence of multiple covalent links
between the two halves, and the many polar residues
buried between the sandwiched β sheets. This suggests
that AdoMetDC was an oligomer of identical chains origi-
nally, and that the AdoMetDC gene was duplicated to
give a single polypeptide chain.
The major differences between the two halves of the
AdoMetDC monomer lie in a few regions of the structure
(Figure 5). The α helices H4 and H10 are very similar and
overlap well, although the strand β5 preceding helix H4 is
longer than its counterpart, strand β13, and leads into a
single turn of 310 helix before beginning helix H4. This
extension of strand β5 includes Cys82, a conserved and
functionally important residue located near the pyruvoyl
cofactor. In the C-terminal sheet, four adjacent β strands
(β10, β11, β12 and β13) are elongated by an average of
three residues each. These strand elongations also contain
functionally important residues, including His243, which is
required for processing and catalytic activity. A β turn
observed between strands β15 and β16 in the C-terminal
half is replaced in the N-terminal half by a β bulge in
strand β8, which, as discussed previously, is involved in the
dimerization interaction. In the two halves, the segment
connecting strand β1 to β2 and that connecting strand β9 to
β10 (residues 20–51 and 183–215, respectively) are quite
different, as are the segments connecting strands β6 to β7
and β14 to β15 (residues 117–143 and 288–309).
Key residues of the active site
As mentioned previously, the break between the α and
β chains (and hence, the catalytic pyruvoyl residue) is
located far from the dimer interface, within the loop
region connecting strands β3 and β4. The two pyruvoyl
groups of the dimer are 54 Å apart, and each is located on
the edge of a large pocket between the two β sheets.
Sequence alignments of representative eukaryotic
AdoMetDCs (Figure 6) reveal this pocket as one of
several areas of high sequence conservation. Open to
solvent on one side, this cavity is surrounded by residues
from strand β1, the loop between β3 and β4, the end of
strand β5, the loop between β10 and β11, and the strand
β12. The cavity is positioned between the two topologi-
cally equivalent halves in an arrangement analogous to the
location of active sites at domain interfaces. The residues
facing this cavity are displayed in Figure 7a.
Much of what is known about the mechanisms of
AdoMetDC’s processing and catalytic reactions comes
from early studies of HisDC [30]. The proposed proen-
zyme processing mechanism has been recently validated
by the observation of a trapped ester intermediate in the
crystal structure of AspDC [27]. In the cleavage reaction,
an ester intermediate is formed when the sidechain
oxygen atom of Ser68 performs a nucleophilic attack on
the mainchain carbonyl carbon atom of Glu67 (Figure 8a).
A β elimination occurs across the Cα and Cβ of Ser68,
resulting in a dehydroalanine at residue 68 and a new C
terminus at residue 67. Residue 68 is then converted to
the pyruvoyl residue by a two-step reaction with water [5].
The pyruvoyl moiety functions as an electron sink for the
catalytic decarboxylation reaction in a manner similar to
that of the cofactor PLP [6]. The decarboxylation reaction
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Figure 4
AdoMetDC dimer with the α and β subunits of each monomer
depicted in contrasting colors. (Figures 4, 5 and 7 were prepared
using Ribbons [49].)
begins with the formation of a Schiff base between the
pyruvoyl cofactor and the α-amino group of the substrate,
AdoMet (Figure 8b). The resulting electron sink facili-
tates the removal of the α-carboxylate group from the sub-
strate; this leaving group is then replaced by a proton.
Finally, the Schiff base is hydrolyzed to yield the decar-
boxylated product [6].
Site-directed mutagenesis has identified six of the
residues facing the pyruvoyl-containing pocket as crucial
to the catalytic reaction: Glu8, Glu11, Ser68, Cys82,
Ser229 and His243 [31,32]. To investigate possible
modes of substrate binding, attempts to model the cova-
lent substrate–enzyme intermediate (Schiff base) were
undertaken using the program AUTODOCK [33]. The
pocket appears large enough to accommodate the sub-
strate without requiring conformational changes to the
enzyme structure. Docking experiments produced a
series of orientations of similar low energy. The position
of the AdoMet carboxylate group is consistent among the
five lowest-energy solutions; however, because of the
conformational flexibility of the long AdoMet molecule,
the consistency of the various docking results breaks
down as one proceeds further from the covalent attach-
ment site. Surrounding the carboxylate are a pyruvoyl
carbonyl group, the OH of Ser229, and the hydrophobic
residues Phe223 and Val64. Additionally, the backbone
amino and carbonyl groups of Leu65 seem to be oriented
towards the AdoMet carboxylate group. The position of
the sulfonium atom is not well defined, with the sulfur
positions of the five lowest energy docking solutions dif-
fering by up to 2.1 Å and showing no consensus in the
position of the attached methyl group. Residues in this
region of the pocket include Thr245, and the backbone
of Ile244. The ribose moiety of the substrate lies
between the phenyl rings of Phe7 and Phe223 and
adopts a series of different orientations. The relative
position of Glu247 indicates that it may form hydrogen
bonds with the ribose OH groups; however, previous
mutation of Glu247 to Gln showed no significant effect
on catalytic activity of the enzyme [31]. The positioning
of the adenine group varies greatly between the various
docking solutions, and shows no consistent interactions
with the enzyme.
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Figure 5
The structurally similar halves of AdoMetDC.
(a) Ribbon diagram showing the structurally
related halves of AdoMetDC colored
according to secondary structure. Two
disordered loops are indicated by black
dashed lines; the third disordered loop
connects the two structurally related halves
and is not shown. (b) Topology diagrams of
the structurally similar halves.
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As has been demonstrated for other pyruvoyl enzymes
and decarboxylation reactions [6], both the AdoMetDC
proenzyme processing and the catalytic activity of the
mature enzyme are expected to require at least one
proton donor and one acceptor. The proximity of the α-
chain pyruvoyl 68 and Ser69 to the β-chain Glu67 in the
processed enzyme suggests that no major structural
rearrangements of the enzyme occur upon processing.
Thus, the best candidates for the proton donor/acceptor
for both the cleavage and the catalytic reactions lie within
the series of conserved residues positioned around the
proposed active-site pocket (Figure 7a). Cys226, Thr245,
and Glu247 seem to be too distant from the pyruvoyl-
defined cleavage/activity site to serve this function, and,
in addition, mutagenesis studies of these residues yielded
no significant alteration in processing and only some inhi-
bition (in the T245A mutant) of catalytic activity [31,34].
Despite their proximity to the cleavage site, residues
Glu67 and Ser69 are also unlikely to be required proton
donors or acceptors, as neither the mutation E67Q nor
S69A affects the processing or catalytic activity [31]. The
mutations E8Q, E11Q, and C82A do not prevent process-
ing [31], so these three residues are unlikely to serve as
the proton donors/acceptors for the autocatalytic proen-
zyme cleavage reaction. However, each of these three
mutations results in loss of catalytic activity and, thus, any
one of these residues might be a required proton donor or
acceptor for the decarboxylation reaction. Glu8 is the least
likely candidate because its sidechain is pointed away
from the active-site pocket.
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Figure 6
Sequence alignment prepared using the GCG
Wisconsin package (Genetics Computer
Group, Madison, WI) and ALSCRIPT [50].
Fully conserved residues are highlighted in red;
partially conserved residues are highlighted in
yellow. The numbering corresponds to the
human sequence, with the first digit of the
number over the corresponding residue. The
eight sequences shown were selected from
the more than 25 known eukaryotic AdoMetDC
sequences to be representative of the most
diverse phylogenetic branches and to avoid a
statistical bias in favor of the (over-
represented) mammalian and plant AdoMetDC
sequences.
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Structure
Mutation of either Ser229 or His243 to alanine produces a
non-processing AdoMetDC proenzyme [32]. These muta-
genesis data and the observed structural proximity of these
two residues to the proenzyme cleavage site make Ser229
and His243 the best candidates for the proton donor and
proton acceptor in the proenzyme cleavage reaction. Since
the mutant enzymes do not self-cleave, they are also enzy-
matically inactive. Consequently, the mutagenesis data
cannot be used to decide whether these residues might
also participate in proton transfers during the decarboxyla-
tion reaction. However, their locations in the three-dimen-
sional structure are consistent with this possibility.
Cocrystallization of the enzyme with substrate and sub-
strate analogs will help clarify the proton donors and accep-
tors involved; such studies are underway in our laboratory.
Key residues for putrescine activation of processing and
activity
The region between the β sheets, in the core of the sand-
wich, contains several pockets of bound water and a
grouping of charged residues. This observation differs
sharply from the typically hydrophobic nature of the inte-
riors of β sandwiches and of protein structures in general,
and it provokes the question of what function this
unusual structure might play. These charged residues,
shown in Figure 7b, include Glu11, Glu15, Arg76, Lys80,
Asp174, Glu178 and Glu256, several of which are con-
served in AdoMetDC sequences across all eukaryotic
species [34]. Additionally, mutation of any of the residues
Glu11, Lys80, Asp174, Glu178 or Glu256 in human
AdoMetDC results in an enzyme that folds and processes,
but whose cleavage reaction is no longer stimulated by
putrescine [8,31,34]. The combination of the mutational
data and the unusual concentration of negatively charged
residues located between the β sheets suggests that this
region might be a potential site for interactions with posi-
tively charged putrescine molecules. This hypothesis is
currently being investigated in our laboratory.
Mutagenesis studies [8,32] have also identified another
series of conserved residues (Tyr112, Arg114 and His127),
which, when mutated to alanine, have strong effects on
the activity of the enzyme and another residue, Glu133,
which, when mutated, affects both the enzyme activity
and the putrescine activation of processing. These
residues interact with one another but, surprisingly, are
removed from the active site, dimer interface, and the
charged intersheet regions, participating instead in inter-
actions between strand β6, helix H6, and the loop region
connecting helices H5 and H6.
Biological implications
The polyamines spermidine and spermine are ubiquitous
in all living cells and are involved in a number of cellular
processes. In particular they seem to play an important
role in cellular growth, as depletion of polyamines
through specific inhibitors blocks cell growth and pre-
vents or diminishes the response normally seen after a
variety of growth-promoting stimuli. The two control
points of the polyamine synthetic pathway, S-adenosyl-
methionine decarboxylase (AdoMetDC) and ornithine
decarboxylase (ODC), have both been widely studied as
antitumor drug targets; inhibitors with potent antitumor
and antiparasitic activity have already been designed for
both enzymes.
The human AdoMetDC structure, determined in this
study, presents a new protein fold and establishes the dif-
ference between AdoMetDC and the two other known
pyruvoyl decarboxylase structures. The lack of similarity
between these three pyruvoyl decarboxylase structures
suggests that the cleavage and decarboxylation mecha-
nisms shared by the enzymes are likely to have evolved
by convergent rather than divergent evolution. The inter-
nal structural repeat observed within the AdoMetDC
structure suggests that the protein may be a product of an
ancient gene duplication. 
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Figure 7
Proposed binding regions for substrate and
effector. (a) Conserved residues surrounding
the proposed active-site cavity. (b) Positions
of the charged residues buried between the
two sheets of the β sandwich.
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Figure 8
Mechanisms of the proenzyme processing
and catalytic reactions. (a) Mechanism of the
AdoMetDC proteolytic proenzyme processing
reaction. (b) Mechanism of the AdoMetDC
pyruvoyl-dependent decarboxylation reaction.
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Putative locations for the active-site cleft and effector-
binding site are predicted using prior mutational data and
the positions of the pyruvoyl cofactor and other con-
served residues. This structural information will be used
to direct biochemical studies of AdoMetDC activity and
proenzyme processing; structural studies of effector and
inhibitor binding are currently being pursued.
Materials and methods
Purification and crystallization
The purification of the human AdoMetDC was facilitated by introducing
its gene into a pQE30 vector, which adds an N-terminal six-histidine
tag (MRGS(His)6GS) to the protein. The plasmid was introduced into
the non-methionine auxotroph Escherichia coli strain JM109 and over-
expressed in ZB medium. The cells were harvested and washed in
M9AA medium, then resuspended in M9AA medium supplemented
with 50 µg/ml selenomethionine and 100 µg/ml isopropyl-β-D-thio-
galactoside (IPTG). The cells were grown for an additional 24 h, har-
vested, suspended in a buffer of 10 mM imidazole, 20 mM NaPO4
pH 7.4, 500 mM NaCl, 2.5 mM putrescine and 0.02% Brij-35 with
1 mg/ml lysozyme and finally lysed by sonication. The supernatant was
filtered through a 0.22 µm syringe filter and loaded onto a Pharmacia
HisTrap column equilibrated with the above buffer. The bound histi-
dine-tagged protein was eluted with the same buffer containing 60 mM
imidazole, and protein-containing fractions were determined by UV
absorbance. The protein was then dialyzed against 10 mM Tris pH 7.5,
2.5 mM putrescine, 2.5 mM dithiothreitol (DTT), 0.02% Brij-35, 0.1 mM
EDTA, 60 mM NaCl, filtered through a 0.22 µm syringe filter, and
loaded on a Millipore DEAE AP-2 column equilibrated with 10 mM Tris
pH 7.5, 2.5 mM DTT, 2.5 mM putrescine, 0.1 mM EDTA, 0.02% Brij-
35. The purified protein was eluted using a gradient from 0 to 2 M
NaCl, concentrated to 5 mg/ml, and stored in 10 mM Tris pH 7.5,
5 mM DTT, 2.5 mM putrescine, 0.1 mM EDTA, 0.02% Brij-35 and
100 mM NaCl at –70°C. The level of selenium incorporation was esti-
mated by comparing mass spectrometry results from the selenomethio-
nine-incorporated and native AdoMetDC protein. The differential
masses of the β chains of the two samples indicated approximately
70% incorporation of selenomethionine in the purified protein. N-termi-
nal sequencing was also used to confirm that the N termini of the
selenomethionine-incorporated α and β chains remained intact. 
It should be noted that the E. coli JM109 cells produce their own
AdoMetDC, although the His-tag purification makes it highly unlikely
that the endogenous protein would copurify with the His-tagged human
enzyme. Additionally, the E. coli AdoMetDC is very different from the
human form in its physical properties (molecular weight, amino acid
composition, etc.). An overloaded sodium dodecyl sulfate polyacry-
lamide gel electrophoresis (SDS–PAGE) gel of the purified AdoMetDC
lacked a visible band at the molecular weight of the E. coli enzyme.
Prior to crystallization, the purified protein was exchanged into a 10 mM
Tris-HCl, 200 mM NaCl, pH 7.5 buffer and concentrated to approxi-
mately 9 mg/ml. Small initial crystals were obtained using the Crystal
Screen sparse matrix kit [35]. The optimized crystallization conditions
were found to be 12–16% PEG 8K, 10 mM Tris-HCl, pH 8.0 using the
hanging-drop method at room temperature. Crystals appeared within a
day, and reached their maximum size of 0.4 mm × 0.3 mm × 0.2 mm
within several days. Crystals kept longer than a few weeks began to
disintegrate in the drop, so fresh crystals were used for diffraction.
Under these conditions AdoMetDC crystallizes in the monoclinic space
group P21 with unit-cell dimensions of a = 74.6 Å, b = 55.8 Å,
c = 90.1 Å, and β = 109.6°. Each asymmetric unit contains a complete
dimer with a solvent content of 48%.
Data collection and processing
The diffraction experiments were performed at NSLS beamline X-12C
(Brookhaven National Laboratory) using a Brandeis 1K charge-coupled
device (CCD) detector. The crystals were frozen near –180°C in a
gaseous N2 stream to extend the crystal lifetime using a cryoprotectant
solution of 18% glycerol in the mother liquor. The crystals were prone to
cracking, so they were slowly introduced to increasing concentrations of
glycerol, being incubated for 2 min each in solutions containing 2, 5, 8,
10, 13, 15, and 18% glycerol to minimize the shock to the crystal. 
The data were collected at three wavelengths surrounding the sele-
nium K-absorption edge as measured from an energy scan of the
frozen SeMet-incorporated AdoMetDC crystal. Two of these wave-
lengths were chosen to maximize the dispersive (f′) and anomalous (f′′)
scattering components, and a third remote wavelength was chosen to
provide a large dispersive difference when compared with the other
two wavelengths. Diffraction data were collected using inverse-beam
geometry and an oscillation angle of one degree. Six sets of 130 dif-
fraction images (direct and inverse beam for each wavelength) were
each collected as a single 130° sweep, and indexed separately using
the program DENZO [36]. The data for each wavelength were then
scaled together using the program SCALEPACK [36]. Crystal and
data collection statistics are shown in Table 1. All six data sets were
processed to 2.25 Å resolution as a result of the positioning of the
detector. However, the crystal diffracted well beyond this resolution;
the I/σ in the highest resolution shell ranged from 11.7 to 15.0.
MAD phasing
Two different methods were used independently to determine the posi-
tions of the 24 anomalous scatterers present in the asymmetric unit.
Twenty peaks were located using the program SOLVE (v. 1.01) [19],
which is based on an automated iterative Patterson search technique;
20 is the maximum number of heavy atoms that SOLVE v. 1.01 is pro-
grammed to find. These 20 selenium-atom positions yielded phases
with a figure of merit of 0.64 and a map that had clear solvent bound-
aries, but was not interpretable. The selenium positions were indepen-
dently determined using SnB, an iterative direct methods program,
which minimizes the minimal function [37–39] using the Shake and
Bake algorithm [17,18]. For input into SnB, diffE values were calcu-
lated for the peak wavelength data using a series of routines written by
RH Blessing [17,40]. A total of 4519 anomalous differences were con-
verted to E values. SnB trials (850) were performed using the 2000
largest E values, 2 × 104 triple phase relationships and 30 phase-
refinement cycles. Selecting fewer E values yielded an inadequate
number of triple phase relationships, resulting in failed runs character-
ized by the absence of a bimodal distribution of Rmin. After optimization
of these input parameters, SnB yielded a reproducible set of 22 heavy-
atom positions with success rates of roughly 10%. The selenium posi-
tions generated by SnB agreed with the 20 generated by SOLVE in all
successful trials. Two of the 24 selenium atoms were not resolved
using either method, and they were later shown to be disordered in the
refined structure. Using a graphics display it was possible to pair up
the selenium atoms and estimate the location of the noncrystallo-
graphic twofold axis. The selenium positions were later confirmed by
calculating an anomalous difference map using the anomalous differ-
ences (∆F) from the peak wavelength and calculated phases from a
partially refined model.
The positions, occupancies, and B factors of the 22 selenium atoms
were refined using isomorphous and anomalous differences between
Bijvoet pairs (∆F values), with the maximum-likelihood method incorpo-
rated in MLPHARE [22] of the CCP4 software package, yielding exper-
imental phases to 2.2 Å with an overall figure of merit of 0.65. Phasing
statistics are presented in Table 2. After applying solvent flattening and
histogram matching with the program DM [41], the resulting map was
readily interpretable (Figure 2), showing several helices and many
β strands arranged in a four-layer α/β-sandwich architecture.
Model building and refinement
The two molecules of the dimer were built independently using the
interactive graphics program O [42] by first building a polyalanine
model through clear stretches of backbone density, then deciphering
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the connectivity and sequence alignment within the structure. The
many selenomethionines, isoleucines, and large aromatic residues pro-
vided clear markers, facilitating this process and reducing the chances
of tracing errors. However, several segments of the protein were
missing in the experimental electron density; the initial model was
about 85% complete.
Refinement of the initial model against the remote wavelength MAD
data was carried out using X-PLOR [43]. All reflections above 2σ in the
range from 20 Å to 2.25 Å resolution were used in refinement, apart
from a 5% randomly selected test set used for calculation of Rfree [44].
A flat bulk-solvent model and noncrystallographic symmetry (NCS)
restraints were used throughout refinement. Alternate cycles of rebuild-
ing, positional refinement, simulated annealing, B-factor refinement, and
water placement were performed as supported by decreases in Rfree.
The protein model was assessed using the program PROCHECK [45].
The Ramachandran plot [46] showed 89.6% of the residues in the
most favored region and 9.7% in the additional allowed region.
Residue Gln300 of each monomer lies in the disallowed region, but
has good electron density and reappears in omit maps. Final refinement
statistics and measures of model quality are presented in Table 2.
Accession numbers
The atomic coordinates have been deposited in the PDB with acces-
sion number 1jen.
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